A comprehensive view of Generics / Biosimilars. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

MA S2520: Improves pharmaceutical access, cost regulation, and transparency
Published: July 25, 2024 by Massachusetts 193rd General Court
CVS Caremark announces renewed pledge for transparency and lower drug costs; commits to less than $8 out-of-pocket costs for 30-day medicine supply and passing on 99% of negotiated rebates
Published: July 22, 2024 by CVS Health Corp.
GoodRx partners with Boehringer Ingelheim for cash buydown program on Adalimumab-adbm; initiative offers low cash price for citrate-free biosimilar on GoodRx platform
Published: July 19, 2024 by Industry Intelligence Inc.
Teva Pharmaceutical strengthens environmental sustainability and supply chain in Europe; 9 out of 10 products made locally, reducing transportation impact and preventing drug shortages
Published: July 17, 2024 by Industry Intelligence Inc.
PhRMA emphasizes the critical role of IP protections in fostering pharmaceutical innovation; highlights 90% of pharmacy-dispensed medicines are generics or biosimilars enabled by IP
Published: July 16, 2024 by Industry Intelligence Inc.

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count